Compugen (NASDAQ:CGEN – Get Rating) and ProKidney (NASDAQ:PROK – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This is a breakdown of current ratings and recommmendations […]
StockNews.com assumed coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a research note published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the company. Jefferies Financial Group cut Compugen from a hold rating to an underperform […]
StockNews.com started coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities research analysts have also recently weighed in on the stock. SVB Leerink reiterated an outperform rating on shares of Compugen in a research report […]
Investment analysts at StockNews.com initiated coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a note issued to investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. Several other research analysts have also commented on CGEN. SVB Leerink restated an “outperform” rating on shares of Compugen in a research […]
StockNews.com began coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a research report sent to investors on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities analysts also recently issued reports on the stock. SVB Leerink restated an outperform rating on shares of Compugen in a research […]